In cancer, including breast cancer, visfatin induces inflammation and immunosuppression, mainly through NF-kB regulation [136] as well as cell proliferation and apoptosis inhibition through AKT/PI3K and ERK/MAPK signaling [137]. This evidence concerns the gene AKT1 and breast cancer.